We are hiring! If you are a highly motivated bioinformatician with experience in scRNA-seq and multiome analysis, please apply! We have a 3 year position! Thanks to a recently funded project by CRIS contra el cáncer to work on pancreatic cancer research 👇
pro.idibell.cat/ConvocatoriasP…

Thrilled that our collab with Malaka Ameratunga Monash University on #drugrepurposing in oncology is out pubmed.ncbi.nlm.nih.gov/38629623/ 14% of cancer patients that currently have no treatment options could potentially benefit from drugs approved for other indications! IDIBELL Institut Català d'Oncologia

La reutilització de #medicaments : noves oportunitats per als pacients oncològics.
L’abordatge computacional del reaprofitament de #fàrmacs prediu que un significatiu percentatge del 14% podrien tractar-se amb teràpies ja aprovades.
ico.gencat.cat/ca/detall/noti…

💊La reutilització de medicaments: noves oportunitats per als pacients oncològics.
🖥️L’abordatge computacional del reaprofitament de fàrmacs prediu que un significatiu percentatge del 14 % dels pacients podrien tractar-se amb teràpies ja aprovades.
▶️idibell.cat/2024/04/la-reu…

Can not studying popular genes cost you your career?!
Check out how the probability of a junior scientist to transition to a principal investigator is lower if the genes they research are less studied. The overall decreasing probability is also really depressing! (from Fig. S10)

There's never been a disease-modifying drug for Parkinson's disease to slow its progression. Now there may be two emerging.
—GLP-1
nejm.org/doi/abs/10.105… NEJM
—anti-synuclein antibody nature.com/articles/s4159…
NATURE.med

👏 👏 👏 👏 👏 👏 👏 🐲 data!
nature.com/articles/s4159…

Un plaer haver-hi participat i apres dels pacients, les seves families i tots els professionals encarregats del tractament i acompanyament d’aquesta malaltia. Esperem poder posar el nostre granet de sorra des de la recerca per avançar cap a un tractament mes efectiu!

Chaired by our founder and CSO, Jordi Mestres (Universitat de Girona), the 24th #EuroQSAR (22-26 Sept, Barcelona) is an excellent chance to attend one of the most important scientific events in the field of #computational #drug #design . chemotargets.com/24th-european-…

Nirogacestsat: A Discarded Alzheimer’s Drug Becomes the First Approved Gamma-Secretase Inhibitor | drughunters.com/3xgLwF7

-2023 Molecule of the Year Nominee (#6/10)-

PÒDCAST 🎙️ | Un fàrmac contra el càncer obre una nova via de tractament del Parkinson

▪️Albert Solé Bonamusa en parla amb Albert A. Antolin (he/him) del @ProcureICO de IDIBELL i l'
Institut Català d'Oncologia

#SantCugat
bit.ly/48U6Ops

And Leticia Manén was awarded 2nd best poster award for our research on repurposing drug metabolites!! Really proud! #iDR24 REMEDi4ALL #proudPI PoC: CellChemicalBiology cell.com/cell-chemical-… #DrugRepurposing

Terrific 1st day at #iDR24 conference REMEDi4ALL if you are interested in our approach to repurpose drug metabolites come check Leticia Manén poster summarizing our strategy and PoC on rucaparib’s metabolite just published CellChemicalBiology cell.com/cell-chemical-… #DrugRepurposing .

Ahead of #internationalwomensday I want to share an article from a while ago that changed my perspective, the way I do research & contributed to the way I now run the lab

cell.com/molecular-cell…

Adrian Saurin MTT based assays are useless in many contexts
The issue with CDK4/6 inhibitors goes beyond that, as im_Iswarya has found the hard way. Crystal violet is pretty useless too with this type of drug.
Taking note of the DNA assay!
Easier than the most reliable: counting cells

Fresh from the biotech pipeline: record-breaking FDA approvals go.nature.com/3v00GOl

1️⃣9️⃣ de febrero, Día Internacional contra la LGTBIfobia en el Deporte en honor al nacimiento de Justin Fashanu, primer futbolista en decir que era gay. La homofobia y el ostracismo lo llevaron al suicidio. Si buscáis por la red encontraréis este interesante documental.

Interesting!

Next week we will hold the first webinar of the Early Career Scientists Group of SEQT #SEQT_ECS with talks from Carles Galdeano and Maria Majellaro. You can't miss it!
Sign up for free: us06web.zoom.us/meeting/regist…

🔬Job Opportunity Alert!🌟
Join our team as a Bioinformatician. If you're passionate about unraveling genomic mysteries and decoding biological data in blood disorders, this role is for you! Apply now! Deadline: 25/02/24 #Bioinformatics #ResearchJobs 🧬💻

pro.idibell.cat/ConvocatoriasP…